We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stem Cells from Knee Fat Become Bone and Fat Cells

By Biotechdaily staff writers
Posted on 21 May 2002
Adult stem cells taken from knee fat have been turned into cartilage, bone, and fat cells by researchers at Duke University Medical Center (Durham, NC, USA). More...
The resulting cells have the potential to be grown into tissue that could be used to repair or replace diseased or damaged tissue.

The researchers took the fat pads from patients whose knee joints were removed during total joint replacement surgery and focused on adipose-derived stromal cells that normally would transform themselves into fat pad cells. After the samples were treated with enzymes and centrifuged, the separated stromal cells were treated with a cocktail of steroids and growth factors. By controlling their biochemical environment and controlling their shape in a 3-D matrix, the researchers were able to grow different cell types from the stem cells. To grow cartilage, groups of cells were infused into a matrix made of alginate, which is often used as the basis for bioabsorbable dressings.

The fat pad is a dense structure behind the kneecap that is different from the typical fat found throughout the body. Although its function is not understood, it is known to be metabolized much more slowly than subcutaneous fat.

"By treating these stromal cells with different agents, we were able to induce them to commit to multiple lineages,” said M. Quinn Wickham, a medical student at Duke who presented the research results at the annual meeting of the Orthopedic Research Society in Dallas (TX, USA). "These findings suggest that the fat pad, give its location and accessibility, may prove to be an excellent source of progenitor cells for tissue engineering or other cell-based therapies.”


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.